MAREX GROUP PLC (MRX) Stock Fundamental Analysis
NASDAQ:MRX - GB00BMT7GT62 - Common Stock
34.94 USD
-0.6 (-1.69%)
34.94 USD
0 (0%)
MRX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 239 industry peers in the Capital Markets industry. MRX may be in some trouble as it scores bad on both profitability and health. MRX is evaluated to be cheap and growing strongly. This does not happen too often!
1. Profitability
1.1 Basic Checks
MRX had positive earnings in the past year.
MRX had a positive operating cash flow in the past year.
1.2 Ratios
MRX's Return On Assets of 1.12% is on the low side compared to the rest of the industry. MRX is outperformed by 62.76% of its industry peers.
With an excellent Return On Equity value of 31.32%, MRX belongs to the best of the industry, outperforming 96.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 31.32% | ||
| ROIC | N/A |
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MRX has a Profit Margin of 10.07%. This is comparable to the rest of the industry: MRX outperforms 41.00% of its industry peers.
MRX's Profit Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 39.98%, MRX is doing worse than 63.18% of the companies in the same industry.
MRX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 10.07% | ||
| GM | 39.98% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.18%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
2. Health
2.1 Basic Checks
MRX has more shares outstanding than it did 1 year ago.
MRX has a better debt/assets ratio than last year.
2.2 Solvency
MRX has an Altman-Z score of 0.22. This is a bad value and indicates that MRX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.22, MRX is doing worse than 70.71% of the companies in the same industry.
The Debt to FCF ratio of MRX is 9.64, which is on the high side as it means it would take MRX, 9.64 years of fcf income to pay off all of its debts.
MRX's Debt to FCF ratio of 9.64 is in line compared to the rest of the industry. MRX outperforms 55.65% of its industry peers.
A Debt/Equity ratio of 11.17 is on the high side and indicates that MRX has dependencies on debt financing.
The Debt to Equity ratio of MRX (11.17) is worse than 89.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 11.17 | ||
| Debt/FCF | 9.64 | ||
| Altman-Z | 0.22 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
MRX has a Current Ratio of 1.09. This is a normal value and indicates that MRX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MRX (1.09) is comparable to the rest of the industry.
MRX has a Quick Ratio of 1.08. This is a normal value and indicates that MRX is financially healthy and should not expect problems in meeting its short term obligations.
MRX's Quick ratio of 1.08 is in line compared to the rest of the industry. MRX outperforms 49.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
MRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.86%, which is quite impressive.
MRX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 50.51% yearly.
Looking at the last year, MRX shows a very strong growth in Revenue. The Revenue has grown by 22.42%.
Measured over the past years, MRX shows a very strong growth in Revenue. The Revenue has been growing by 36.98% on average per year.
EPS 1Y (TTM)48.86%
EPS 3Y50.51%
EPS 5YN/A
EPS Q2Q%13.33%
Revenue 1Y (TTM)22.42%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%18.48%
3.2 Future
MRX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.42% yearly.
MRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.75% yearly.
EPS Next Y26.99%
EPS Next 2Y18.36%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue Next Year24.79%
Revenue Next 2Y16.8%
Revenue Next 3Y13.75%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 10.13, which indicates a very decent valuation of MRX.
74.06% of the companies in the same industry are more expensive than MRX, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.06. MRX is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 8.30, which indicates a very decent valuation of MRX.
MRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. MRX is cheaper than 86.61% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MRX to the average of the S&P500 Index (22.69), we can say MRX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.13 | ||
| Fwd PE | 8.3 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MRX indicates a rather cheap valuation: MRX is cheaper than 94.98% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.58 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MRX's earnings are expected to grow with 16.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y18.36%
EPS Next 3Y16.42%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.63%, MRX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 7.91, MRX is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 2.32, MRX is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.63% |
5.2 History
MRX has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DPN/A
EPS Next 2Y18.36%
EPS Next 3Y16.42%
34.94
-0.6 (-1.69%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners50.51%
Inst Owner Change0%
Ins Owners6.62%
Ins Owner ChangeN/A
Market Cap2.55B
Analysts81.54
Price Target51.91 (48.57%)
Short Float %5.91%
Short Ratio2.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.63% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.83%
Min EPS beat(2)-0.13%
Max EPS beat(2)9.79%
EPS beat(4)3
Avg EPS beat(4)9.72%
Min EPS beat(4)-0.13%
Max EPS beat(4)18.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.45%
Min Revenue beat(2)0.89%
Max Revenue beat(2)6.01%
Revenue beat(4)4
Avg Revenue beat(4)4.48%
Min Revenue beat(4)0.89%
Max Revenue beat(4)8.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.72%
PT rev (3m)15%
EPS NQ rev (1m)2.84%
EPS NQ rev (3m)19.11%
EPS NY rev (1m)7.09%
EPS NY rev (3m)10.52%
Revenue NQ rev (1m)4.32%
Revenue NQ rev (3m)13.94%
Revenue NY rev (1m)6.05%
Revenue NY rev (3m)9.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.13 | ||
| Fwd PE | 8.3 | ||
| P/S | 0.74 | ||
| P/FCF | 1.58 | ||
| P/OCF | 1.55 | ||
| P/B | 2.29 | ||
| P/tB | 3.07 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.45
EY9.87%
EPS(NY)4.21
Fwd EY12.05%
FCF(TTM)22.18
FCFY63.49%
OCF(TTM)22.48
OCFY64.35%
SpS47.39
BVpS15.24
TBVpS11.37
PEG (NY)0.38
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 31.32% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 10.07% | ||
| GM | 39.98% | ||
| FCFM | 46.81% |
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.18%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
F-Score5
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 11.17 | ||
| Debt/FCF | 9.64 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 93.16% | ||
| Cap/Sales | 0.63% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 464.71% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 0.22 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)64.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.86%
Cap/Sales(5y)N/A
Profit Quality(3y)452.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.86%
EPS 3Y50.51%
EPS 5YN/A
EPS Q2Q%13.33%
EPS Next Y26.99%
EPS Next 2Y18.36%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue 1Y (TTM)22.42%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%18.48%
Revenue Next Year24.79%
Revenue Next 2Y16.8%
Revenue Next 3Y13.75%
Revenue Next 5YN/A
EBIT growth 1Y-15.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.82%
EBIT Next 3Y13.77%
EBIT Next 5YN/A
FCF growth 1Y58.23%
FCF growth 3Y35.14%
FCF growth 5YN/A
OCF growth 1Y58.37%
OCF growth 3Y35.22%
OCF growth 5YN/A